Literature DB >> 8062141

Ovarian hormone status, life-style factors, and markers of bone metabolism in women aged 50 years.

A Leino1, J Järvisalo, O Impivaara, M Kaitsaari.   

Abstract

Fifty-year-old women (n = 519) attending a health examination were divided by their ovarian hormone status into four groups: premenopausal, perimenopausal, postmenopausal without ovarian hormone replacement therapy (HRT), and postmenopausal with HRT. Information on lifestyle factors was obtained with interviews and questionnaires. Bone mineral density at the calcaneus was assessed with single-photon absorptiometry, and several serum and urine markers of bone metabolism were measured. Postmenopausal women without HRT had significantly higher levels of fasting serum alkaline phosphatase, osteocalcin, total and ionized calcium, phosphate, and fasting urinary hydroxyproline than those in the three other study groups. No difference was found in bone mineral density between the premenopausal and postmenopausal groups. Postmenopausal women without HRT showed a marked correlation between serum osteocalcin and urine hydroxyproline. Both markers showed significant correlations with serum calcium, phosphate, and alkaline phosphatase. Multivariate analyses showed a statistically significant association of ovarian hormone status and body mass index with most measured markers of bone metabolism. The association between alcohol consumption and serum osteocalcin was highly significant. Cigarette smoking was associated with levels of serum alkaline phosphatase and total and ionized calcium. A weak association was found between coffee drinking and serum alkaline phosphatase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062141     DOI: 10.1007/bf00295948

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  31 in total

1.  Potential risk factors for development of postmenopausal osteoporosis--examined over a 12-year period.

Authors:  M A Hansen; K Overgaard; B J Riis; C Christiansen
Journal:  Osteoporos Int       Date:  1991-02       Impact factor: 4.507

2.  Osteoporosis of the slender smoker revisited by epidemiologic approach.

Authors:  G F Jensen
Journal:  Eur J Clin Invest       Date:  1986-06       Impact factor: 4.686

3.  Recommended methods for the determination of four enzymes in blood.

Authors: 
Journal:  Scand J Clin Lab Invest       Date:  1974-06       Impact factor: 1.713

4.  Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women.

Authors:  M Horowitz; A G Need; J C Philcox; B E Nordin
Journal:  Am J Clin Nutr       Date:  1984-06       Impact factor: 7.045

5.  Evidence of a toxic effect of ethanol on bone in rats.

Authors:  T C Peng; S C Garner; G D Frye; M A Crenshaw
Journal:  Alcohol Clin Exp Res       Date:  1982       Impact factor: 3.455

6.  The relative contributions of age and years since menopause to postmenopausal bone loss.

Authors:  B E Nordin; A G Need; B E Chatterton; M Horowitz; H A Morris
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

7.  Use of hormone replacement therapy in 1976-89 by 45-64 year old Finnish women.

Authors:  P Topo; T Klaukka; E Hemminki; A Uutela
Journal:  J Epidemiol Community Health       Date:  1991-12       Impact factor: 3.710

8.  Sex steroids and bone mass. A study of changes about the time of menopause.

Authors:  C Slemenda; S L Hui; C Longcope; C C Johnston
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

9.  Effect of calcium supplementation on bone loss in postmenopausal women.

Authors:  I R Reid; R W Ames; M C Evans; G D Gamble; S J Sharpe
Journal:  N Engl J Med       Date:  1993-02-18       Impact factor: 91.245

10.  Factors affecting bone density in young adults.

Authors:  A M Fehily; R J Coles; W D Evans; P C Elwood
Journal:  Am J Clin Nutr       Date:  1992-09       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.